Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Isaacs

Showing results (461-470 of 499) with videos related to

Pageof 50
Sort By:
Nature Genetics|September 24, 2002
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer riskJianfeng Xu, S Lilly Zheng, Akira Komiya, et al.
Genetic Epidemiology|February 18, 2017
gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernelsNicholas B Larson, Shannon McDonnell, Lisa Cannon Albright, et al.
European Urology|December 20, 2016
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at DeathRong Na, S Lilly Zheng, Misop Han, et al.
Plos One|June 8, 2010
Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studiesKatherine S Elliott, Eleftheria Zeggini, Mark I McCarthy, et al.
Human Genetics|June 6, 2016
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21Craig C Teerlink, Daniel Leongamornlert, Tokhir Dadaev, et al.
American Journal of Human Genetics|September 27, 2016
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsNilah M Ioannidis, Joseph H Rothstein, Vikas Pejaver, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2010
Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2Ludmila Prokunina-Olsson, Yi-Ping Fu, Wei Tang, et al.
European Urology Oncology|January 13, 2021
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium StudyQuesta Karlsson, Mark N Brook, Tokhir Dadaev, et al.
Human Genetics|December 27, 2011
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)Guangfu Jin, Lingyi Lu, Kathleen A Cooney, et al.
Human Molecular Genetics|May 5, 2007
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer GeneticsNicola J Camp, Lisa A Cannon-Albright, James M Farnham, et al.
Pageof 50

Showing results (461-470 of 499) with videos related to

Sort By:
Pageof 50
Nature Genetics|September 24, 2002
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer riskJianfeng Xu, S Lilly Zheng, Akira Komiya, et al.
Genetic Epidemiology|February 18, 2017
gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernelsNicholas B Larson, Shannon McDonnell, Lisa Cannon Albright, et al.
European Urology|December 20, 2016
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at DeathRong Na, S Lilly Zheng, Misop Han, et al.
Plos One|June 8, 2010
Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studiesKatherine S Elliott, Eleftheria Zeggini, Mark I McCarthy, et al.
Human Genetics|June 6, 2016
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21Craig C Teerlink, Daniel Leongamornlert, Tokhir Dadaev, et al.
American Journal of Human Genetics|September 27, 2016
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsNilah M Ioannidis, Joseph H Rothstein, Vikas Pejaver, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2010
Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2Ludmila Prokunina-Olsson, Yi-Ping Fu, Wei Tang, et al.
European Urology Oncology|January 13, 2021
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium StudyQuesta Karlsson, Mark N Brook, Tokhir Dadaev, et al.
Human Genetics|December 27, 2011
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)Guangfu Jin, Lingyi Lu, Kathleen A Cooney, et al.
Human Molecular Genetics|May 5, 2007
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer GeneticsNicola J Camp, Lisa A Cannon-Albright, James M Farnham, et al.
Pageof 50